PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
October 07, 2022 09:00 ET
|
PharmaCyte Biotech, Inc.
LAS VEGAS, Oct. 07, 2022 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), a biotechnology company focused on evaluating its signature live-cell...
PharmaCyte Biotech Appoints Dr. Linda S. Sher as Chief Medical Officer
July 26, 2017 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., July 26, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
PharmaCyte Biotech Appoints Dr. Michael M. Abecassis to Board of Directors
July 10, 2017 09:30 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., July 10, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
PharmaCyte Biotech Releases Presentation to Oncologists and Interviews from 2017 ASCO Meeting Event
July 06, 2017 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., July 06, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing cellular therapies for cancer and diabetes...
PharmaCyte Biotech to Present Pancreatic Cancer Therapy at 2017 BIO International Convention
June 13, 2017 09:20 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., June 13, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing cellular therapies for cancer and diabetes...
PharmaCyte Biotech Updates Shareholders on ASCO Presentation to Oncologists
June 09, 2017 09:20 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., June 09, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing cellular therapies for cancer and diabetes...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 09:20 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., May 31, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
PharmaCyte Biotech Updates IND Submission Process in Interview with Facet Life Sciences
May 08, 2017 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., May 08, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
PharmaCyte Biotech Appoints Thomas Yuen to Board of Directors
May 02, 2017 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., May 02, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
PharmaCyte Biotech Receives the 2017 “Pipelines of Promise” Award from BIO International
April 19, 2017 09:20 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., April 19, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...